Article Versions Notes

De Wyn J, Zimmerman MW, Weichert-Leahey N, Nunes C, Cheung BB, Abraham BJ, Beckers A, Volders P-J, Decaesteker B, Carter DR, et al. MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation. Cancers. 2021; 13(19):4783. https://doi.org/10.3390/cancers13194783

De Wyn, Jolien, Mark W. Zimmerman, Nina Weichert-Leahey, Carolina Nunes, Belamy B. Cheung, Brian J. Abraham, Anneleen Beckers, Pieter-Jan Volders, Bieke Decaesteker, Daniel R. Carter, and et al. 2021. "MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation" Cancers 13, no. 19: 4783. https://doi.org/10.3390/cancers13194783

De Wyn, J., Zimmerman, M. W., Weichert-Leahey, N., Nunes, C., Cheung, B. B., Abraham, B. J., Beckers, A., Volders, P.-J., Decaesteker, B., Carter, D. R., Look, A. T., De Preter, K., Van Loocke, W., Marshall, G. M., Durbin, A. D., Speleman, F., & Durinck, K. (2021). MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation. Cancers, 13(19), 4783. https://doi.org/10.3390/cancers13194783